BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)
CUSIP: 10806X102
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 201,803,957
- Total 13F shares
- 141,085,070
- Share change
- +20,152,077
- Total reported value
- $8,688,930,801
- Put/Call ratio
- 212%
- Price per share
- $61.60
- Number of holders
- 194
- Value change
- +$1,238,074,220
- Number of buys
- 146
- Number of sells
- 59
Quarterly Holders Quick Answers
What is CUSIP 10806X102?
CUSIP 10806X102 identifies BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 10806X102:
Top shareholders of BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. |
13F
|
Company |
17%
|
34,510,971
|
$2,454,075,000 | — | 31 Dec 2020 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
13%
|
26,620,991
|
$1,893,019,000 | — | 31 Dec 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.3%
|
6,706,268
|
$476,883,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.2%
|
6,517,544
|
$463,464,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
6,441,312
|
$458,042,000 | — | 31 Dec 2020 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.3%
|
4,711,604
|
$335,042,000 | — | 31 Dec 2020 | |
| Aisling Capital Management LP |
13F
|
Company |
2%
|
3,989,412
|
$283,687,000 | — | 31 Dec 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
1.7%
|
3,342,334
|
$237,673,000 | — | 31 Dec 2020 | |
| SC US (TTGP), LTD. |
13F
|
Company |
1.3%
|
2,544,738
|
$180,956,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
2,296,523
|
$163,306,000 | — | 31 Dec 2020 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.1%
|
2,265,762
|
$161,118,000 | — | 31 Dec 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.88%
|
1,783,535
|
$126,827,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
0.7%
|
1,411,271
|
$100,356,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.67%
|
1,354,419
|
$96,313,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
1,209,721
|
$86,023,000 | — | 31 Dec 2020 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.53%
|
1,073,966
|
$76,370,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.41%
|
832,836
|
$59,222,000 | — | 31 Dec 2020 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.39%
|
777,031
|
$55,253,000 | — | 31 Dec 2020 | |
| Darwin Global Management, Ltd. |
13F
|
Company |
0.33%
|
662,958
|
$47,143,000 | — | 31 Dec 2020 | |
| NORGES BANK |
13F
|
Company |
0.31%
|
632,984
|
$45,011,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.31%
|
626,485
|
$44,549,000 | — | 31 Dec 2020 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.3%
|
606,760
|
$43,147,000 | — | 31 Dec 2020 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
0.27%
|
544,127
|
$38,693,000 | — | 31 Dec 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.27%
|
540,353
|
$38,424,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.26%
|
528,443
|
$37,578,000 | — | 31 Dec 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.21%
|
422,936
|
$30,075,000 | — | 31 Dec 2020 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.2%
|
411,771
|
$29,281,000 | — | 31 Dec 2020 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.17%
|
346,880
|
$24,667,000 | — | 31 Dec 2020 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.17%
|
346,000
|
$24,604,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.17%
|
339,060
|
$24,111,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
322,475
|
$22,931,000 | — | 31 Dec 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.15%
|
300,000
|
$21,333,000 | — | 31 Dec 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.14%
|
284,069
|
$20,200,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
271,782
|
$19,327,000 | — | 31 Dec 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.13%
|
252,865
|
$17,981,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
234,283
|
$16,660,000 | — | 31 Dec 2020 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.11%
|
220,408
|
$15,672,000 | — | 31 Dec 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.1%
|
201,689
|
$14,342,000 | — | 31 Dec 2020 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.09%
|
190,273
|
$13,530,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
180,153
|
$12,811,000 | — | 31 Dec 2020 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.09%
|
179,706
|
$12,778,000 | — | 31 Dec 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.08%
|
165,402
|
$11,761,737 | — | 31 Dec 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
164,589
|
$11,704,000 | — | 31 Dec 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.08%
|
157,900
|
$11,228,000 | — | 31 Dec 2020 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.08%
|
155,000
|
$11,022,000 | — | 31 Dec 2020 | |
| Fernwood Investment Management, LLC |
13F
|
Company |
0.07%
|
150,835
|
$10,726,000 | — | 31 Dec 2020 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
141,849
|
$10,087,000 | — | 31 Dec 2020 | |
| Man Group plc |
13F
|
Company |
0.07%
|
137,985
|
$9,812,000 | — | 31 Dec 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
125,900
|
$8,953,000 | — | 31 Dec 2020 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
119,021
|
$8,464,000 | — | 31 Dec 2020 |
Institutional Holders of BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) as of Q1 2021
As of 31 Mar 2021,
BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) was held by
194 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
141,085,070 shares.
The largest 10 holders included
Kohlberg Kravis Roberts & Co. L.P., VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Aisling Capital Management LP, HILLHOUSE CAPITAL ADVISORS, LTD., AMERICAN INTERNATIONAL GROUP, INC., JANUS HENDERSON GROUP PLC, and SC US (TTGP), LTD..
This page lists
194
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
160
Q1 2021 holders
194
Holder diff
34
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.